T-cell lymphoma (peripheral, relapsed or refractory) - romidepsin: EIA - scoping
Documents
Documents created during the development process.
T-cell lymphoma (peripheral, relapsed or refractory) - romidepsin: EIA - scoping
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: Institute's response to consultee and commentator comments on the draft scope and provisional matrix
-
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: Institute's response to consultee and commentator comments on the draft scope and provisional matrix
-
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: final matrix
-
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: final matrix
-
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: final matrix (PDF 56 KB)
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: final scope
-
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: final scope
-
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: final scope (PDF 49 KB)
Appendix B - draft scope for consultation (pre-referral) - July 2011
-
Appendix B - draft scope for consultation (pre-referral) - July 2011
-
Appendix B - draft scope for consultation (pre-referral) - July 2011 (PDF 55 KB)
Appendix C - provisional matrix (pre-referral) - July 2011
-
Appendix C - provisional matrix (pre-referral) - July 2011
-
Appendix C - provisional matrix (pre-referral) - July 2011 (PDF 64 KB)